AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
2.400
-0.050 (-2.04%)
Oct 13, 2026, 4:00 PM EDT - Market closed
AC Immune Market Cap
AC Immune has a market cap or net worth of $238.62 million as of October 13, 2026. It is the 19,689th most valuable company in the world and the 3,425th biggest in the United States. Its market cap has decreased by 33.20% in one year.
Market Cap
238.62M
Enterprise Value
150.44M
1-Year Change
-33.20%
Global Rank
Country Rank
#3,425 United States
Category
ChartMarket Cap Chart
Since September 23, 2016, AC Immune's market cap has decreased from $867.50M to $238.62M, a decrease of -72.49%. That is a compound annual growth rate of -12.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 12, 2026 | 249.30M | -21.31% |
| Dec 31, 2025 | 316.80M | 17.51% |
| Dec 31, 2024 | 269.60M | -36.36% |
| Dec 29, 2023 | 423.60M | 145.85% |
| Dec 30, 2022 | 172.30M | -52.25% |
| Dec 31, 2021 | 360.80M | -2.88% |
| Dec 31, 2020 | 371.50M | -35.46% |
| Dec 31, 2019 | 575.60M | 6.20% |
| Dec 31, 2018 | 542.00M | -25.42% |
| Dec 29, 2017 | 726.70M | 1.07% |
| Dec 30, 2016 | 719.00M | -17.12% |
| Sep 23, 2016 | 867.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vogenx | 260.86M |
| Upstream Bio | 257.42M |
| Immuneering | 254.91M |
| Vicore Pharma Holding AB | 253.39M |
| Lineage Cell Therapeutics | 251.39M |
| Zentalis Pharmaceuticals | 249.93M |
| Q32 Bio | 248.28M |
| Greenwich LifeSciences | 242.63M |